News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Solvay Pharmaceuticals, Inc. Starts Buyback, Still Looking at Acquisitions; Shares will be Held, Not Cancelled


2/16/2010 6:51:36 AM

Bookmark and Share

Reuters -- Belgian chemicals firm Solvay surprised investors with a 356 million euro share buyback but said it still plans to use a 1.7 billion euro ($2.3 billion) gain from the sale of its drugs unit to finance acquisitions.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES